Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3299caff5645aed7d063df2f1d2f4b10 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-50 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-28 |
filingDate |
1997-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92f5e7814a74a64dc575888045b0cb1b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29732872004ac35536a73f8926649406 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d57b5bbaf1910311cf4e8fdfd02133f |
publicationDate |
2000-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20000048643-A |
titleOfInvention |
Insulin c-peptides |
abstract |
The present invention relates to a peptide which is a fragment of human insulin C-peptide, comprising the sequence ELGGGPGAG or a fragment thereof, or the peptide sequence EGSLQ or a fragment thereof, and having the ability to stimulate Na + K + ATPase activity. It also provides a biomimetic organic compound characterized by Na + K + ATPase activating capacity and / or cell binding properties to renal tubule cells and fibroblasts above the level exhibited by the peptide or fragment specified above. These peptides and compounds have the use of coping with diabetes and / or diabetic complications or stimulating Na + K + ATPase activity. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160081035-A |
priorityDate |
1996-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |